A detailed history of Colonial Trust CO / Sc transactions in Embecta Corp. stock. As of the latest transaction made, Colonial Trust CO / Sc holds 120 shares of EMBC stock, worth $1,696. This represents 0.0% of its overall portfolio holdings.

Number of Shares
120
Previous 137 12.41%
Holding current value
$1,696
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$10.13 - $14.6 $172 - $248
-17 Reduced 12.41%
120 $1,000
Q1 2024

May 13, 2024

SELL
$12.35 - $19.33 $111 - $173
-9 Reduced 6.16%
137 $1,000
Q4 2023

Feb 14, 2024

SELL
$12.87 - $19.09 $450 - $668
-35 Reduced 19.34%
146 $2,000
Q3 2023

Nov 13, 2023

SELL
$15.0 - $22.17 $345 - $509
-23 Reduced 11.27%
181 $2,000
Q2 2023

Aug 14, 2023

BUY
$21.6 - $30.69 $432 - $613
20 Added 10.87%
204 $4,000
Q4 2022

Feb 14, 2023

BUY
$25.29 - $35.48 $4,653 - $6,528
184 New
184 $4,000

Others Institutions Holding EMBC

About Embecta Corp.


  • Ticker EMBC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 57,836,500
  • Market Cap $818M
  • Description
  • Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...
More about EMBC
Track This Portfolio

Track Colonial Trust CO / Sc Portfolio

Follow Colonial Trust CO / Sc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Colonial Trust CO / Sc, based on Form 13F filings with the SEC.

News

Stay updated on Colonial Trust CO / Sc with notifications on news.